Hepatic steatosis cohort: effects on ANGPTL3 levels
Mean (s.d.) percentage change in ANGPTL3 from baseline at day 113 was −85.3% (12.7%) for the 200-mg dose compared to an increase of 13.0% (4.7%) for placebo (Extended Data Table 